EDRE
GLMD icon

Edmond de Rothschild (Europe)’s Galmed Pharmaceuticals GLMD Stock Holding History

Edmond de Rothschild (Europe)’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$4K Hold
5
– – ﹤0.01% 230
2016
Q2 		$4K Hold
5
– – ﹤0.01% 218
2016
Q1 		$5K Hold
5
– – ﹤0.01% 221
2015
Q4 		$7K Hold
5
– – ﹤0.01% 241
2015
Q3 		$7K Buy
5
+3
+150% +$4.93K ﹤0.01% 238
2015
Q2 		$4K Buy
+2
New +$3.48K ﹤0.01% 262

Other funds holding GLMD

6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $131M AUM 46.14% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $126M AUM 15.32% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
WJA
Williams Jones & Associates New York $4.82B AUM 19.95% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.46B AUM 33.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Edmond de Rothschild (Europe)'s GLMD Position: Q3 2016 in Review

Edmond de Rothschild (Europe) held its Galmed Pharmaceuticals (GLMD) position steady in Q3 2016 at 5 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #230.

Edmond de Rothschild (Europe) first reported a position in GLMD in Q2 2015 and has held it in 6 quarters since. The position peaked at $7K in Q4 2015. 17 funds tracked by Wall St. Rank hold GLMD as of Q3 2016.

  • Edmond de Rothschild (Europe) held 5 shares of Galmed Pharmaceuticals worth $4K as of Q3 2016.
  • Edmond de Rothschild (Europe) left its Galmed Pharmaceuticals share count unchanged in Q3 2016.
  • Galmed Pharmaceuticals made up ﹤0.01% of Edmond de Rothschild (Europe)'s portfolio in Q3 2016, its #230 holding.
  • Edmond de Rothschild (Europe) first reported a position in Galmed Pharmaceuticals in Q2 2015 and has held it in 6 quarters since.
  • Edmond de Rothschild (Europe)'s Galmed Pharmaceuticals position peaked at $7K in Q4 2015.
  • 17 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q3 2016.

Based on Edmond de Rothschild (Europe)'s 13F filing for Q3 2016, filed 14 Nov 2016.